BACKGROUND: Obesity is frequently associated with an increase in the early inflammation marker C-reactive protein (CRP), insulin resistance and changes in lipoprotein metabolism. Increased CRP is known as an independent cardiovascular risk factor. Since the apolipoproteins (apo) E and CIII components of HDL are associated with reduced cardiovascular risk and since apoE has in vitro anti-inflammatory effect, we have investigated the relationships between apoE, apoCIII (in apoB and non apoB containing lipoproteins) and CRP in obese adults.
Introduction
Various studies performed on obese children and adults 1 -5 have established that overweight and obesity are associated with systemic inflammation as determined by serum level of C-reactive protein (CRP). In long-term prospective studies, increased serum CRP level was shown to be a risk factor for coronary heart disease. 6 -10 According to clinical and population studies, the relationship between inflammation and obesity has also been suggested by in vitro data showing pro-inflammatory cytokines production by adipose tissue, such as TNF-a. 11 TNF-a is particularly interesting since numerous studies have suggested that it could play a key role in cardiovascular disease 12, 13 and also in insulin resis-tance syndrome by inhibiting insulin signaling, 14 lipolysis 15 and by inducing hypertriglyceridemia. 16 Obesity is frequently associated with insulin resistance syndrome. 17 This syndrome (X syndrome) is characterised by a wide array of pathophysiologic sequelae including intraabdominal depots of fat (android obesity), hypertension, impaired glucose tolerance, hyperinsulinemia, changes in lipoprotein metabolism and atherosclerosis. 17, 18 Hypertriglyceridemia and reduced HDL-cholesterol concentration resulting from these changes may explain increased cardiovascular risk associated with X syndrome. 15, 19 Lipoproteins involved are mainly triglyceride rich apoB-containing lipoproteins (LpB) and HDL, non apoB containing lipoproteins (LpnonB). Apolipoproteins E and CIII, both components of LpB and LpnonB particles, could play a role in the pathogenesis of the disease. ApoE and apoCIII are actually first transferred from HDL to triglyceride-rich lipoproteins. 20 -22 After lipolysis by lipoprotein lipase and hepatic lipase, apoE and CIII are again transferred to HDL. 23 -27 Thus, relative distribution of apoE and apoCIII between LpB and LpnonB lipoproteins is related to lipolytic cascade since lipoprotein lipase activity is inversely correlated with insulin resistance degree and hyperinsulinemia. 27, 28 In obese subjects with insulin resistance, hypertriglyceridemia was shown to be associated with an increase in CIII LpB and E LpB and, to a lesser extent, a decrease in CIII LpnonB and E LpnonB. 29 However, influence of apoCIII and apoE distribution between lipoproteins on cardiovascular risk was suggested by other studies. ApoCIII associated with HDL (CIII LpnonB) was negatively correlated with lesion progression in CLAS study 30 whereas apoCIII associated with apoB containing lipoprotein (CIII LpB) was positively correlated with lesion progression in MARS study. 31 Studies on animal models, including transgenic 32 -35 or knock-out mice 36 -40 and familial studies 41, 42 suggest that apoE can prevent coronary heart disease. In addition, in vitro studies 43 -49 and animal models 50 have suggested an anti-inflammatory effect of apoE. Changes in lipoprotein metabolism and insulin resistance associated with obesity could play a crucial role in cardiovascular disease of obese adults and could be responsible for their systemic inflammation. To test this hypothesis, we explored, in a population of obese and mainly insulin resistant women, the links of serum CRP level, with two of its proposed determinants ie the insulin resistance parameters and the lipid parameters related to X syndrome. We have also studied the relationships between CRP and proinflammatory or pro-insulin resistance cytokine secreted by adipose tissue, TNF-a and sTNFR2, its soluble receptor. 15 
Materials and methods

Subjects and sampling
Thirty-four Caucasian obese women volunteers were included in the study. Apart from obesity, all subjects were in good health. None were engaged in any type of exercise program or was excessively sedentary. None were suffering from any infection as assessed by clinical examination, platelets and leukocytes formulation. Subjects taking medications known to affect plasma lipid levels were excluded. All were inpatients for 1 week before the study and were given the same isocaloric diet during this time. At approximately 8 am after an overnight fast, a blood sample was drawn, centrifuged and serum was divided into aliquots and kept at 7 80 C before analysis. For each subject, waist (WC) and hip circumferences, systolic (SBP) and diastolic (DBP) blood pressure were measured. Body mass index (BMI ¼ weight (kg)=height 2 (m 2 )) and waist -hip ratio (WHR) were calculated.
Analytical methods
Blood level of glucose, cholesterol, triglyceride and HDLcholesterol (HDL-C) were assayed enzymatically using a multiparametric analyzer (Hitachi 747, Roche, Meylan, France). LDL-cholesterol was calculated with the Friedewald formula. 51 Serum insulin concentrations were measured using commercial RIA kits (Bi-Insulin IRMA; ERIA-Pasteur, Paris, France). Serum levels of TNF-a and TNFR2 were determined by enzyme-linked immunosorbent assay (R&D Systems, Oxford, UK). High sensitivity C-reactive protein (CRPhs) was assessed by immuno-nephelometry on Behring Nephelometer 2 (Dade-Behring, La Défense, France). Insulin sensitivity was calculated using the homeostasis model assessment (HOMA ¼ (glucose (mmol=l)Âinsulin (UI=l))= 22.5), a mathematical estimate of insulin sensitivity based on fast glucose and insulin concentrations. 52 Total serum apoE was measured by electroimmunoassay (Sebia, Issy-les-Moulineaux, France). ApoE bound to apoB (E LpB) and not bound to apoB (E LpnonB) were obtained by precipitation with an anti-apoB antibody (as adapted from Alaupovic). 53 Total apoCIII, apoCIII bound to apoB (apoCIII LpB) and not bound to apoB (apoCIII LpnonB) were measured using the same method as for apoE. The ratio between apoE LpB and apoCIII LpB (E=CIII LpB) was used to estimate the relative proportion of apoE and apo CIII in LpB particles. Similarly, the ratio between apoE LpnonB and apoCIII LpnonB (E=CIII LpnonB) was used to estimate the relative proportion of apoE and apoCIII in LpnonB particles.
ApoE isoforms were determined on plasma delipidated with ethanol=ether (3V=1V) by preparative isoelectric focusing (IEF) on 7.5% polyacrylamide-urea (8 M) gels (pH gradient 4 -7). 54 
Statistical analysis
Results were analyzed using SAS statistical software (SAS Institute Inc., Cary, NC, USA). For non-normally distributed variables (BMI, SBP, DBP, insulin, HOMA, HDL-C, apoE, E=CIII LpB, E=CIII LpnonB, CRP, TNF-a), values were logtransformed before linear correlation and multiple regression analyses. Linear correlation (Pearson) was used to look at relationships between variables. A multiple stepwise Apolipoprotein E and C-reactive protein in obesity K Bach-Ngohou et al regression procedure, including parameters related to CRP with a P-value below 0.25, was performed to explore their independent contribution to CRP concentration. The first model tested included BMI, WC, HOMA, insulin, triglyceride, apoE and E LpnonB. The second took into account E=CIII LpnonB ratio and all the parameters previously included in the first model. Significance levels are shown for all relationships where P is below 0.05.
Results
Studied population
Clinical and biological characteristics of the subjects studied are presented in Table 1 . Among the 34 obese women selected, two thirds were insulin resistant and showed intra-abdominal obesity (android) as measured, respectively, by homeostasis model assessment (HOMA > 2.5) and waisthip ratio (WHR > 0.9). All subjects were slightly hypercholesterolemic (cholesterol > 5.16 mmol=l). ApoE and apoCIII concentrations (total, in LpB and LpnonB lipoproteins) were mostly within the normal range but were widely distributed. Similar findings could be observed for insulin, TNF-a, TNFR2 and CRP concentrations. Table 2 presents the relationship between CRP, TNF-a and TNFR2 with obesity and insulin resistance parameters. CRP correlates positively with BMI, WC and triglyceride levels. No correlation was found between HOMA and CRP. TNF-a correlates positively with BMI and negatively with HDL-C. The most significant relationships are found with TNFR2, obesity related rate (BMI, WC, WHR) and insulin resistance (positive correlation with HOMA and insulin, negative correlation with HDL-C). We did not find any correlation between CRP and neither TNF-a nor TNFR2. A good correlation was found between TNF-a and TNFR2. Table 3 shows univariate analysis between CRP or cytokine and lipid lipoprotein and apolipoproteins. Significant negative correlation between CRP and total apoE concentration was found. This relation was mainly due to apoE associated with HDL lipoprotein (E LpnonB). No correlation was found between TNF-a or TNFR2 and lipid, lipoprotein and apolipoprotein parameters except a negative correlation between TNF-a and apoCIII.
Univariate analysis
Multiple stepwise regression analysis
Stepwise multiple regression model including parameters related to CRP with a P-value below 0.25 was run to assess their independent contribution to CRP concentration (Table  4) . When BMI, WC, HOMA, insulin, triglyceride, apoE and E LpnonB were included in the model, total serum apoE concentration was the best predictor of CRP concentration, together with triglyceride concentration and BMI. ApoE had a negative relationship with CRP level, independent of transformed. *P < 0.05; **P < 0.01; ***P < 0.0001.
Apolipoprotein E and C-reactive protein in obesity K Bach-Ngohou et al triglyceride. Within the 40% of CRP variance explained by these three parameters, 19% was related to apoE. When E=CIII LpnonB ratio, representing the relative content of LpnonB in apoE and CIII, was included in the model, this ratio appeared to be the best predictor of CRP level together with BMI, instead of apoE and triglyceride. E=CIII LpnonB had a stronger negative influence on CRP level than apoE and explained 22% of CRP variance.
Discussion
We have found a strong and inverse relation between CRP levels and total apoE or E LpnonB levels. Using multiple regression analysis, we have shown that total apoE has a negative and independent influence on serum CRP level, explaining 19% of CRP variance. To our knowledge, this is the first time that such a relation between apoE and inflammation has been shown in obese subjects. Among the obese women studied, systemic inflammation was extending from very low to consequent grade since CRP concentration varied from very small (0.5 mg=l) to consequent value (19.8 mg=l) according to the results of the National Heart and Nutrition Examination Survey. 1 We have found that biological parameters and particularly apoE and apoCIII concentrations were widely distributed, showing the disparity in apoE and CIII distribution among our population studied.
While Yudkin et al 5 and Hak et al 4 have shown that CRP is positively correlated with insulin resistance parameters, namely HOMA, blood pressure, HDL-cholesterol and triglyceride, we did not find any relation between CRP levels and these insulin resistance parameters, except triglyceride. This could result from the difference between the population studied. While our population was dramatically obese with BMI extending from 28 to 64 kg=m 2 , Yudkin et al and Hak et al have studied overweight subjects with highest BMI, respectively, of 28.9 and 29.5 kg=m 2 . It may be that dramatic increase in BMI leads to an absence of evident relation between insulin resistance and inflammation. Only triglyceride still positively correlates with CRP. This result could suggest that in obese adults with important BMI, changes in triglyceride rich lipoprotein metabolism could lead to inflammation or, inversely, that systemic inflammation could modify triglyceride-rich lipoprotein metabolism.
We have measured serum levels of TNF-a and its soluble receptor TNFR2. TNFR2 could be a possible marker of insulin resistance related to obesity. 15 We found that TNF-a and TNFR2 were positively correlated with BMI. However, TNFR2 correlated positively and very significantly with WC and WHR while TNF-a did not. As an increased WC and an increased WHR are associated with abdominal obesity, this finding could suggest that in obese subjects TNF-a may be mostly secreted locally by intra-abdominal adipose tissue and may not reach circulation while TNFR2 does. Local and intra-abdominal adipose tissue secretion of TNF-a has been reported by Mohamed-Ali 55 and is consistent with an autocrin and paracrin and not endocrin secretion of TNF-a by adipose tissue. 17 Our results are in agreement with Hotamisligil results 15 suggesting that serum TNFR2 level could be a better marker of insulin resistance-related obesity than TNF-a level since HOMA strongly correlates with TNFR2 and not with TNF-a. Moreover, TNF-a correlated very strongly with TNFR2 level. This could suggest that TNFR2 might play a role in human obesity by modulating the action of TNF-a. We found no correlation between either TNF-a or TNFR2 and CRP level, suggesting that in obese adults with such obesity this cytokine would not have pro-inflammatory effect in vivo or that CRP level is influenced by other mediators not related to TNF-a.
The main finding of our study is the inverse relationship between CRP and apoE serum levels. It is not possible to conclude if it is a reduced apoE level in obese adults which leads in part to low grade inflammation, expressed by increased CRP level or, inversely, if it is low grade systemic inflammation which leads to reduced apoE level. However, in vitro cellular studies have suggested an anti-proliferative role of apoE on T lymphocytes, 45, 55 smooth muscle cells 44, 46 and microglia. 47 Indirect in vivo anti-inflammatory role of apoE has also been suggested in apoE knock-out mice model. 50 According to these studies, our findings may suggest indirectly an in vivo anti-inflammatory effect of apoE in obese Apolipoprotein E and C-reactive protein in obesity K Bach-Ngohou et al subjects with reduced apoE levels leading to increased inflammation. Using multiple regression model analysis including E=CIII LpnonB, we have found that this ratio was the best predictor of CRP level together with BMI, explaining in itself 22% of CRP level. E=CIII LpnonB reflects the relative number of apoE per apoCIII molecules in HDL. This suggests that in vivo, (1) apoE contained in HDL may have an antiinflammatory effect, and (2) this effect may depend on HDL content in apoCIII. If the latter is present in too large quantity relative to apoE in the HDL particle, it could interfere with apoE anti-inflammatory effect. CRP is produced early by the liver during the inflammation process. Hepatic apoE synthesis has been shown in vitro to be decreased by inflammatory cytokines such as TNF-a. 56 Therefore, the inverse relationship between CRP and apoE could reflect a positive effect of TNF-a on CRP on the one hand and a negative effect of TNF-a on apoE on the other. However, the lack of any relation between TNF-a and TNFR2 with either CRP or apoE, argues in favor of a direct effect of apoE on CRP circulating level.
Some studies have suggested that CRP is not only a marker of acute phase response, but could also be involved in the pathogenesis of the disease, acting directly within the atherosclerotic vessels or ischemic myocardium by activation of the complement system, thereby promoting inflammation and thrombosis. 57 ApoE may play a cardioprotective role in liver site promoting cholesterol homeostasis 58, 59 or directly in lesion area. 59, 60 Like cytokines, 61 apoE may also interfere with CRP synthesis by the liver. However, we cannot exclude a negative effect of CRP on apoE synthesis either by the liver or by the macrophage, leading to lower levels of apoE containing lipoproteins or inhibiting local apoE anti-inflammatory effect.
Three main isoforms are known for apolipoprotein E: e2, e3 and e4. 54 Therefore, the question of a specific effect of each isoform on CRP may be raised. In our study population, 22 subjects were phenotyped as e3=e3 and 12 were phenotyped as e3=e4. A separate correlation analysis (data not shown) revealed that apoE (r ¼ 7 0.40, P ¼ 0.09) tends to be correlated to CRP and E LpnonB (r ¼ 7 0.52; P ¼ 0.02) is significantly correlated to CRP in the e3=e3 subgroup while no significant correlation is found neither for apoE (r ¼ 7 0.30, P ¼ 0.37) nor for apoE LpnonB (r ¼ 7 0.14, P ¼ 0.67) in the e3=e4 subgroup. However, the number of subjects in each subgroup is too low to draw a definitive conclusion on a potential specific effect of apoE isoforms on inflammation. Further studies should clarify this point.
In summary, we have shown a strong negative relation between CRP and apoE plasma levels in obese adults. This relation could concern mainly HDL-apoE and be interacted by apoCIII. This work raises questions; (1) what is the nature of the interaction between CRP and apoE? (2) What is the implication of apoE in low grade systemic inflammation of obese adults? If apoE really plays a protective role in inflammation pathogenesis, modulating apoE metabolism may be one possible way to protect from cardiovascular disease associated with inflammation. Clinical studies with drugs modulating apoE metabolism should focus on this point.
